Necrotizing fasciitis in captive juvenile Crocodylus porosus caused by Streptococcus agalactiae: An outbreak and review of the animal and human literature

Epidemiology and Infection

Volumn 135, Issue 8, 2007, Pages 1248-1255

  Bishop, E J ^a   Shilton, C ^b   Benedict, S ^b   Kong, F ^c   Gilbert, G L ^c   Gal, D ^a   Godoy, D ^d   Spratt, B G ^d   Currie, B J ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b Fisheries and Mines ^*  (Australia)

^c Western Sydney Area Health Service   (Australia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLIGATOR; ANIMAL TISSUE; AUTOPSY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; EPIDEMIC; MALE; MULTILOCUS SEQUENCE TYPING; NECROTIZING FASCIITIS; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; STREPTOCOCCUS AGALACTIAE; ANIMAL; ANIMAL DISEASE; BACTERIUM IDENTIFICATION; CLASSIFICATION; EPIDEMIOLOGY; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; SEROTYPING; STREPTOCOCCUS INFECTION;

ALLIGATORS AND CROCODILES; ANIMALS; BACTERIAL TYPING TECHNIQUES; DISEASE OUTBREAKS; EPIDEMIOLOGY, MOLECULAR; FASCIITIS, NECROTIZING; GENOTYPE; HUMANS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 38449097994     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008515     Document Type: Review

References (60)

1. Wong CH, et al. Necrotising fasciitis: Clinical presentation, microbiology and determinants of mortality. Journal of Bone and Joint Surgery of America 2003; 85: 1454-1460.
2. Headley AJ. Necrotising soft tissue infections: A primary care review. American Family Physician 2003; 68: 323-328.
3. Giuliano A, et al. Bacteriology of necrotising fasciitis. American Journal of Surgery 1977; 134: 52-56.
4. Liu Yuag-Meng, et al. Microbiology and factors affecting mortality in necrotising fasciitis. Journal of Microbiology Immunology and Infection 2005; 38: 430-435.
5. Gaunt N, et al. Necrotising fasciitis due to group C and G haemolytic streptococcus after chiropody. Lancet 1984; 1: 516.
6. Gotoff SP. Group B streptococcal infections. Pediatric Reviews 2002; 23: 381-385.
7. Lang ME, Vaudry W, Robinson JL. Case report and literature review of late-onset group B streptococcal disease manifesting as necrotising fasciitis in preterm infants: Is this a new syndrome? Clinical Infectious Diseases 2003; 37: E132-135.
8. Bomar Jr. WE, Ferlauto JJ, Wells DH. An unusual presentation of a 13-hemolytic group B streptococcal infection. Journal of Pediatric Surgery 1980; 15: 683-685.
9. Ramamurthy RS, Srinivasan G, Jacobs NM. Necrotising fasciitis and necrotising cellulitis due to group B streptococcus. American Journal of Diseases of Childhood 1977; 131: 1169-1170.
10. Vianni RM, Lewis A, Bradley JS. Postoperative group B streptococcal necrotising fasciitis in a previously healthy child. Pediatric Infectious Disease Journal 1997; 16: 630-631.
11. Crum NF, Wallace MR. Group B streptococcal necrotising fasciitis and toxic shock-like syndrome: A case report and review of the literature. Scandanavian Journal of Infectious Diseases 2004; 35: 878-881.
12. Riefler J, et al. Necrotising fasciitis in adults due to group B streptococcus. Report of a case and review of the literature. Archives of Internal Medicine 1988; 148: 727-729.
13. Matsubara K, et al. Three fatal cases of invasive sero-type VI group B streptococcal infection. Journal of Infection 2006; 53: E139-142.
14. Tang WM, et al. Report of 2 fatal cases of adult necrotising fasciitis and toxic shock syndrome caused by Streptococcus agalactiae. Clinical Infectious Diseases 2000; 31: E15-17.
15. Gardam MA, et al. Group B streptococcal necrotising fasciitis and streptococcal toxic shock-like syndrome in adults. Archives of Internal Medicine 1998; 158: 1704-1708.
16. Sutton GP, et al. Group B streptococcal necrotising fasciitis arising from an episiotomy. Obstetrics and Gynecology 1985; 66: 733-736.
17. Holmstrom B, Grimsley EW. Necrotising fasciitis and toxic shock syndrome caused by group B streptococcus. Southern Medical Journal 2000; 93: 1096-1098.
18. Wong CH, Kurup A, Tan KC. Group B Streptococcus necrotising fasciitis: An emerging disease? European Journal of Clinical Microbiology and Infectious Diseases 2004; 23: 573-575.
19. Wibawan IWT, Lautrou Y, Lammler C. Antibiotic resistance patterns and pigment production of streptococci of serological group B isolated from bovines and humans. Journal of Veterinary Medicine 1991; 38: 731-736.
20. Yildirim AO, et al. Pheno- and genotypic properties of streptococci of serological group B of canine and feline origin. FEMS Microbiology Letters 2002; 212: 187-192.
21. Lammler C, Abdulmawjood A, Weib R. Properties of serological group B streptococci of dog, cat and monkey origin. Journal of Veterinary Medicine 1998; 45: 561-566.
22. Evans JJ, et al. Characterization of β-haemolytic Group B Streptococcus agalactiae in cultured seabream, Spurns auratus L., and wild mullet, Liza klunzingeri (Day) in Kuwait. Journal of Fish Diseases 2002; 25: 505-513.
23. Amborski RL, et al. A non-hemolytic, group B streptococcus infection in cultured bullfrogs, Rana catesbeiana, in Brazil. Journal of Wildlife Diseases 1983; 19: 180-184.
24. Zappulli V, et al. Fatal necrotising fasciitis and myositis in a captive common bottlenose dolphin (Tursiops truncates) associated with Streptococcus agalactiae. Journal of Veterinary Diagnostic Investigation 2005; 17: 617-622.
25. Evans JJ, et al. First report of Streptococcus agalactiae and Lactococcus garvieae from a wild bottlenose dolphin (Torsiops truncatus). Journal of Wildlife Diseases 2006; 42: 561-569.
26. De Winter LM, Prescott JF. Relatedness of Streptococcus canis from canine streptococcal toxic shock syndrome and necrotising fasciitis. Canadian Journal of Veterinary Research 1999; 63: 90-95.
27. Miller CW, et al. Streptococcal toxic shock syndrome in dogs. Journal of the American Veterinary Medical Association 1996; 209: 1421-1426.
28. Hetzel U, et al. Septicaemia in emerald monitors (Varanus prasinus Schlegel 1839) caused by Streptococcus agalactiae acquired from mice. Veterinary Microbiology 2003; 95: 283-293.
29. Schlievert PM, Gocke JE, Deringer JR. Group B streptococcal toxic shock-like syndrome: Report of a case and purification of an associated pyrogenic toxin. Clinical Infectious Diseases 1993; 17: 26-31.
30. Green NM, et al. Genome sequence of a serotype M28 strain of group A Streptococcus: Potential new insights into puerperal sepsis and bacterial disease specificity. Journal of Infectious Diseases 2005; 192: 760-770.
31. Kong F, et al. Towards a genotyping system for Streptococcus agalactiae (group B streptococcus): Use of mobile genetic elements in Australasian invasive isolates. Journal of Medical Microbiology 2003; 52: 337-344.
32. Elliot JA, et al. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. Journal of Clinical Microbiology 1998; 36: 2115-2116.
33. Fasola E, et al. Molecular analysis of multiple isolates of the major serotypes of group B streptococci. Journal of Clinical Microbiology 1993; 31: 2616-2620.
34. Zeng X, et al. Evaluation of a multiplex PCR based reverse line blot hybridisation (mPCR/RLB) for identification or serotype and surface protein antigens of Streptococcus agalactiae (group B streptococcus, GBS). Journal of Clinical Microbiology 2006; 44 3822-3825.
35. Zeng X, et al. Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrobial Agents and Chemotherapy 2006; 50: 204-209.
36. Jones N, et al. Multilocus sequence typing system for group B streptococcus. Journal of Clinical Microbiology 2003; 41: 2530-2536.
37. Keefe GP. Streptococcus agalactiae mastitis: A review. Canadian Veterinary Journal 1997; 38: 429-437.
38. Pasnik DJ, Evans JJ, Klesius PH. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination. Diseases of Aquatic Organisms 2005; 66: 129-134.
39. Buenviaje GN, Ladds PW, Martin Y. Pathology of skin diseases in crocodiles. Australian Veterinary Journal 1998; 76: 357-363.
40. Madsen M. Microbial flora of frozen tail meat from captive Nile crocodiles (Crocodylus niloticus). International Journal of Food Microbiology 1993; 18: 71-76.
41. Zhao Z, et al. Molecular serotype identification of Streptococcus agalactiae of bovine origin by multiplex PCR-based reverse line blot assay. FEMS Microbiology Letters 2006; 263 236-239.
42. Franken C, et al. ISSag1 in streptococcal strains of human and animal origin. International Medical Microbiology 2004; 294 247-254.
43. Herbert MA, Beveridge CJE, Saunders NJ. Bacterial virulence factors in neonatal sepsis: Group B streptococcus. Current Opinion in Infectious Diseases 2004; 17: 225-229.
44. Franken C, et al. Horizontal gene transfer and host specificity of beta-haemolytic streptococci: The role of a putative composite transposon containing scpB and lmb. Molecular Microbiology 2001; 41: 925-935.
45. Rolland K, et al. Genetic features of Streptococcus agalactiae strains causing severe neonatal infection as revealed by pulsed-field gel electrophoresis and hylB gene analysis. Journal of Clinical Microbiology 1999; 37: 1892 1898.
46. Hassell M, et al. Streptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia and comparison with the literature. BMC Infectious Diseases 2004; 4: 60-67.
47. Vlaminckx BJ, et al. Specific manifestations of invasive group A streptococcal disease: Type distribution and virulence determinants. Journal of Clinical Microbiology 2003; 41: 4941-4949.
48. Lindahl G, Stalhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clinical Microbiology Reviews 2005; 18: 102 127.
49. Lamy M-C, et al. CovS/CovR of group B streptococcus: A two-component global regulatory system involved in virulence. Molecular Microbiology 2004; 54: 1250-1268.
50. Herbert MA, et al. Genetic islands of Streptococcus agalactiae strains NEM316 and 2603 VR and their presence in other Group B streptococcal strains. BMC Microbiology 2005; 5: 31-43.
51. Granlund M, et al. Identification of a novel insertion element, IS 1548, in group B streptococci, predominantly in strains causing endocarditis. Journal of Infectious Diseases 1998; 177: 967-976.
52. Sun Y, et al. Comparison of a three-set genotyping system with multilocus sequence typing for Streptococcus agalactiae (group B streptococcus). Journal of Clinical Microbiology 2005; 43: 4704 4707.
53. Merchant M, Britton A. Characterization of serum complement activity of saltwater (Crocodylus porosus) and freshwater ( Crocodylus johnstoni) crocodiles. Comparative Biochemistry and Physiology 2006; 143: 488-493.
54. Musser JM, et al. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proceedings of the National Academy of Sciences USA 1989; 86: 4731-4735.
55. Bisharat N, et al. Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. Journal of Clinical Microbiology 2004; 42: 2161-2167.
56. Brochet M, et al. Genomic diversity and evolution within the species Streptococcus agalactiae. Microbes and Infection 2006; 8: 1227-1243.
57. Bisharat N, et al. Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease. Journal of Clinical Microbiology 2005; 151: 1875-1881.
58. Bohnsack JF, et al. Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerging Infectious Diseases 2004; 10: 1412-1419.
59. Luan SH, et al. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. Journal of Clinical Microbiology 2005; 43: 3727-3733.
60. Johri AK, et al. Group B Streptococcus: Global incidence and vaccine development. Nature Reviews 2006; 4: 932-942.